Background/Aims: Muscle bioactive lipids accumulation leads to several disorder states. The most common are insulin resistance (IR) and type 2 diabetes. There is an ongoing debate which of the lipid species plays the major role in induction of muscle IR. Our aim was to elucidate the role of particular lipid group in induction of muscle IR. Methods: The analyses were performed on muscle from the following groups of rats: 1. Control, fed standard diet, 2 HFD, fed high fat diet, 3. HFD/Myr, fed HFD and treated with myriocin (Myr), an inhibitor of ceramide de novo synthesis. We utilized [U 13 C] palmitate isotope tracer infusion and mass spectrometry to measure content and synthesis rate of muscle long-chain acyl-CoA (LCACoA), diacylglycerols (DAG) and ceramide (Cer). Results: HFD led to intramuscular accumulation of LCACoA, DAG and Cer and skeletal muscle IR. Myr-treatment caused decrease in Cer (most noticeable for stearoyl-Cer and oleoyl-Cer) and accumulation of DAG, possibly due to rechanneling of excess of intramuscular LCACoA towards DAG synthesis. An improvement in insulin sensitivity at both systemic and muscular level coincided with decrease in ceramide, despite elevated intramuscular DAG. Conclusion: The improved insulin sensitivity was associated with decreased muscle stearoyl-and oleoyl-ceramide content. The results indicate that accumulation of those ceramide species has the greatest impact on skeletal muscle insulin sensitivity in rats.
Introduction
High fat diet (HFD) consumption and obesity leads to accumulation of intramuscular lipids that are known to be associated with chronic and severe medical problems including insulin resistance (IR) and type 2 diabetes (T2D). Although it is clear that consumption of HFD leads to IR via intramuscular lipid accumulation, there is an ongoing debate which lipid class is the most important in triggering skeletal muscle insulin resistance. Skeletal muscles are responsible for 70-80% of whole body insulin-stimulated glucose uptake, and therefore the main organ affected by insulin resistance. Skeletal muscle also plays an important role in lipid metabolism. Plasma free fatty acid (FFA) concentration is often elevated in obese and type 2 diabetic subjects as compared to lean, healthy ones [1] . Elevated fatty acid (FA) uptake has been observed in skeletal muscle of individuals with T2D [2] obese humans [3] and subjects fed HFD [4] . After entering the cell, FA are activated to form a fatty acyl-CoA (LCACoA) and this step is catalyzed by the enzyme acyl-CoA synthetase (ACS). Then, the acyl-CoA are directed to the mitochondria for β-oxidation or synthesis of intramyocellular lipids (IMCL) [5] . LCACoA are transported through the mitochondrial membrane as acyl-carnitines that are synthesized by the enzyme carnitine palmitoyltransferase 1 (CPT1). Decreased content of CPT1 was observed in the skeletal muscle of obese individuals suggesting that the ability to direct FA towards β-oxidation is impaired in obesity. It is well known, that malonyl-CoA (a key intermediate in synthesis of fatty acids) inhibits CPT1 and in this way also mitochondrial uptake of FA. The elevated FA uptake by cell with decreased mitochondrial channeling of FA contributes to the accumulation of IMCL. The main groups of lipid which are currently considered to be responsible for induction of muscle IR are: LCACoA, DAG and Cer. Each of them is reported to inhibit the insulin signaling cascade. The accumulation of LCACoAs has been reported in obese, insulin resistant individuals [6] and during HFD feeding [7] . The increased content of intracellular DAG has been demonstrated in the insulin-resistant muscle of HFD rats [8] and Zucker rats [9] . Similarly, muscle Cer accumulation has been observed in muscles of obese, insulin-resistant humans [10] and obese insulin-resistant rats [9, 11] . It has been found that LCACoAs and DAGs affect insulin signaling pathway through the activation of serine/threonine PKC isoenzymes [12] , whereas Cer inhibits the pathway at Akt/PKB level [13] . Other sphingolipid species such as gangliosides [14] or sphingosine-1-phosphate [15] may also contribute to IR.
The aim of this study was to elucidate the role of particular bioactive lipid species in fat-induce IR. We utilized stable isotope labeled [U- 13 C] -palmitate tracer and ultra-highperformance liquid chromatography (UHPLC) -tandem mass spectrometer (LC/MS/MS) to follow the fate of FAs within the cell. Moreover, by the use of chemical inhibitor of Cer denovo synthesis (myriocin) together with an ability to measure FSR of particular lipids, we were able to establish the role of particular lipid class in triggering lipid-induced skeletal muscle IR. Present work answered several important questions concerning intracellular fate of plasma-borne FA, such as dynamics of cellular uptake, activation towards LCACoAs and incorporation into particular class of (IMCL) as well as its role in inhibition of insulin signaling pathway.
Materials and Methods

Animals and study design
The investigation was approved by the Institutional Animal Care and Use Committee of Medical University of Bialystok. The experiments were carried out on male Wistar rats, randomly divided into following groups: 1. Control, fed 8 weeks a control diet (Research Diets INC D12450B, 10% calories from fat) (n = 8). 2. HFD group, fed for 8 weeks high fat-diet (HFD) (Research Diets INC D12492, 60% calories from saturated fat) (n = 8). 3. Myriocin-treated (HFD/Myr) (n = 6) fed for 8 weeks HFD with daily intraperitoneal injection of SPT inhibitor myriocin (0.5 mg/kg, in PBS buffer). One day before infusion experiment, an oral glucose tolerance test (OGTT) and intraperitoneal insulin tolerance tests (ITT) were undertaken. On the last day of the study the [U- [17] with the use of LC/MS/MS. Quantified LCACoA species are listed in Table S3 . The ceramide content and isotopic enrichment was measured using a UHPLC/MS/MS approach according to Blachnio-Zabielska et al. [18] . The content and isotopic enrichment of DAG was measured using a UHPLC/MS/MS approach according to Blachnio-Zabielska et al. [19] . Measured Cer and diacylglycerols molecular species are listed in Table 1 and Table S5 , respectively. Acyl-carnitine concentration and isotopic enrichment ( 13 C 16 -carnitine) was measured according to Sun et al. [20] with minor modification. Both concentration and isotopic enrichment were measured with the use of UHPLC/MS/MS. Table S4 provides measured acyl-carnitine species.
Isotope infusion, tissue collection and lipid fractional synthesis rate calculation (FSR)
The mixture of albumin-bound 13 C 16 -potassium-palmitate (uniformly labeled, Sigma-Aldrich, St. Louis, MO USA) was prepared as previously described [21] . Plasma palmitate concentration and isotopic enrichment in both the infusate and plasma samples was measured according to Persson et al. [16] . Isotope tracer infusion and lipid FSR calculation was performed according to Blachnio-Zabielska et al. [19] . The area under palmitate enrichment curve was identical in all experimental groups (see online suppl. material, Fig.  S1 ) .
Protein and RNA isolation
Total RNA and protein was isolated from muscle samples using NucleoSpin ® RNA/Protein isolation kit (Macherey-Nagel, Bethlehem, PA), according to procedure by Bahn et al. [22] . RNA and proteins were separated on NucleoSpin columns according to manufacturer guidelines.
Western Blot
Following target proteins were quantified using primary antibodies: GLUT4, CD36, CPT1A, (Abcam, Cambridge, MA), ACC, acyl-coenzyme A synthetase (ACS), SPT, Akt, pAktSer473, pAktThr308, AS160, AS160Thr642 and GAPDH (Santa Cruz Biotechnology). Values were normalized to GAPDH protein expression measured from parallel runs and expressed as fold changes over control group values. All chemicals and equipment used for immunoblotting were purchased from Bio-Rad (Hercules, CA).
RT-PCR
The RNA was reverse transcribed into cDNA using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA) with oligo(dT) 18 . Specific primers for the ACC, ACS, CD36, CPT1, FABPpm, FATP1, GLUT4, SPT and GAPDH were designed using the Beacon Designer Software. The housekeeping gene GAPDH was used as the reference gene for quantification. Quantitative real-time PCR was performed with SYBR Green Supermix Kit (Bio-Rad) using a Bio-Rad Chromo4 system. 
Oral Glucose Tolerance Test (OGTT), Insulin Tolerance Test (ITT), plasma insulin and HOMA-IR
OGTT was performed in by oral glucose administration at a dose of 3 g/kg. ITT was performed by intraperitoneal injection of insulin in a dose of 0.75 U/kg body weight. Blood samples from tail vein were measured at given intervals by glucometer (AccuCheck, Roche. Germany). Plasma insulin was measured with an ELISA insulin assay (Rat/Mouse Insulin Millipore). HOMA-IR index value was calculated according to Cacho et al. [24] .
Principal component analysis, correlation analysis and statistical significance estimation PCA was performed using Statistica 10.0 software package as described earlier [25] . To prevent an artificial increase in the PCA model strength, we excluded a majority of closely interdependent variables. We used Pearson's approach with Bonferroni correction for multiple comparisons to establish relationships between selected variables chosen on the basis of PCA analysis. Statistical significance between groups was estimated using ANOVA with the Tukey honestly significant difference post-hoc test for unequal n-numbers. Significance level was set to p < 0.05.
Results
Whole-body insulin sensitivity
Animals fed HFD developed IR, which was manifested by elevated fasting blood glucose concentration, increased HOMA-IR index, reduced insulin responsiveness and impaired glucose tolerance (see online suppl. material, Table S1 , Fig. 1 ). Myriocin normalized insulinrelated parameters to control values.
Plasma FFA concentration, muscle expression of FA transporters, ACS activity, LCACoA content and FSR
Total plasma FFA concentration increased by 30% in HFD group as compared to Control (p < 0.05 vs Control; Fig. 2A ). Myriocin increased plasma FFA by 45% (p < 0.05 vs Control). Fig. 2D ), yet myriocin treatment almost doubled the total LCACoA's in muscle, as compared to both the Control and HFD animals (p < 0.05). All the above changes in the content of LCACoA were most visible for C18:0-acyl-CoA (see online suppl. material, Table S3 ). Enzymatic activity of acyl-CoA synthase (ACS) increased significantly in both the HFD and HFD/Myr groups, yet there were no significant changes in (ACS) mRNA and protein content ( Fig. S3 and Fig. 2E ) or acyl-CoA FSR between experimental groups (see online suppl. material, Fig. S2 ).
Mitochondrial channeling of fatty acids
Both the HFD and HFD/Myr animals displayed significant decrease in FSR and content of acyl-carnitine (p < 0.05 vs Control, Fig. 3 A-D; Table S4 , see online suppl. material). Moreover, in HFD group the expression of CPT1 was lower than respective values in the Control group (p < 0.05 vs Control). The same was noted for acyl-carnitine to LCA-CoA concentration ratio and respective FSR ratio (Fig. 3H, Fig. S4 , see online suppl. material).
Muscle malonyl-CoA content doubled in HFD group as compared to Control group (p < 0.05 vs Control; Fig. 3E ). HFD decreased acetyl-CoA carboxylase (ACC) phosphorylation, which indicates its activation (p < 0.05 vs Control, Fig. 3G ). Myriocin treatment restored the malonyl-CoA content to control values, yet had no effect on ACC gene expression or phosphorylation state, as compared with HFD animals.
Muscle bioactive lipid profile HFD increased the content of muscle ceramide as compared to Control (p < 0.05, Fig.  4A ), which was attributed entirely to stearoyl-and oleoyl-ceramide species (Table 1 ). The (Fig. 4F,G) . In HFD/Myr animals, total DAG content doubled as compared to Control, with C18-derived DAGs responsible for majority of the change.
Skeletal muscle insulin sensitivity
In HFD animals, induction of IR was associated with decreased insulin action at the level of skeletal muscle, as suggested by decreased phosphorylation of Akt (Ser475 and Thr308), and AS160 under insulin stimulation (Fig. 5 A-C) . Improvement of insulin-sensitivity in HFD/Myr was related to significant increase in insulin pathway proteins phosphorylation (Akt Ser475, Akt Thr308 and AS160), as compared to HFD animals (p < 0.05). There were no significant changes in mRNA of GLUT4 between studied groups (see online suppl. material, 
Principal component (PCA) and correlation analysis
We employed PCA analysis to study relationships between individual lipid species and measures of the whole body and skeletal muscle insulin resistance. PCA analysis identified three major principal components, which were responsible for a total of 82.2% of cumulative variance within our data set (pc1 = 43.3%, pc2 = 33.7%, pc3 = 5.2%; cumulative R2X = 0.822, Q2=0.674). Each experimental group clustered tightly on scores biplot (Fig. 6A) . Overlay of variable vectors indicated that factors such as insulin-resistance measurements and stearoyl-, oleoyl-and total ceramide content were responsible for separation of HFD-only group from both the Control and HFD/Myr groups (along t2 axis, Fig. 6A ). Total DAG, total LCA-CoA, their C18:1-derived molecular species and AKT phosphorylation state were responsible for separation of HFD/Myr animals from the other experimental groups (along t1 axis, Fig. 6A ). Variables such as total content and FSR rate of acyl-carnitines and acyl-carnitine to LCA-CoA ratio were responsible for separation of Control group from both HFD-treated groups. Interestingly those variables included also short-chain (C14:0) and very long-chain (C24-based) ceramides. Loadings scatter plot revealed tight clustering of C18:0-, C18:1-and total ceramide content with the measurements of insulin resistance such as HOMA-IR, fasting glucose, OGTT and ITT AUC (Feature cluster 1, Fig. 6B ). Other cluster members were malonyl-CoA and C14:0-CoA. Lipid β-oxidation-related variables clustered together with acyl-carnitine content and FSR and short-chain and very-long chain ceramides and Control group representation (Feature cluster 2, Fig. 6B ). Most of the individual DAG species and total DAG content clustered with total and C18:1-CoA level and AKT phosphorylation (Feature cluster 3, Fig. 6B ). To further confirm interdependency between the muscular lipid species and IR parameters we used Pearson's r correlation estimation. Both, total and C18-chain length ceramides showed strong, positive correlation with HOMA-IR, OGTT AUC, ITT AUC and fasting plasma glucose (r from 0.73 to 0.93, p < 0.001 in all cases). Total ceramide displayed negative correlation with Akt phosphorylation state (r = -0.83, p < 0.001). Content and FSR 
Discussion
Our study was designed to establish which of the bioactive lipid species is the most important in HFD-induced muscle IR. Although the exact mechanism that leads to the development of IR in skeletal muscle is not fully understood, increased uptake of FA, intracellular fat accumulation and bioactive lipids have been shown to play a key role in skeletal muscle IR [26] [27] [28] . Currently, research focus shifts from total intramyocellular fat accumulation to bioactive lipid classes, and further to individual lipid species [29] . With the use of stable isotope tracers and mass spectrometry we followed the fate of plasma FA in HFD-induced intramuscular fat accumulation and IR. Our results indicate that C18:0 and C18:1-derived ceramides, as opposed to diacylglycerols, play a leading role in fat-induced skeletal muscle IR.
Increased rate of muscle FA uptake together with decreased mitochondrial channeling of FA may be responsible for IMCL accumulation. Elevated rates of FA uptake were observed in skeletal muscle of obese or T2DM animals [30] [31] [32] . We found that HFD feeding leads to accumulation of skeletal muscle acyl-CoA due to increased expression of FA transporters and ACS activity. Interestingly, myriocin treatment in HFD animals led to further increase in plasma FA and muscle acyl-CoA content. By blocking sphingoid production at systemic level, myriocin inhibits one of the metabolic pathways of plasma FFA disposal. This affects also intracellular acyl-CoA content which accumulates in skeletal muscle due to inhibition of sphingolipid biosynthesis. Analogous mechanisms were observed in plasma and skeletal muscle of CD36 [33] or CPT1b knock-out mice [34] where blocking of FA uptake to skeletal muscle or mitochondria led to plasma FA and intramuscular lipids accumulation. In the same way PGC-1α protein ablation leads to intracellular TAG accumulation in L6 myotubes due to impaired mitochondrial FA metabolism [35] . Yet despite oversupply of the both plasma FA and muscle acyl-CoA myriocin-treated animals displayed improvement of IR at both systemic and muscular level which points to bioactive lipids as major contributors in IR.
Improvement of IR by augmentation of mitochondrial FA uptake is one of the molecular mechanisms of antidiabetic medication [36, 37] . Thus reduction in muscle mitochondrial FA channeling could be responsible in part for induction of IR. Accumulation of intramuscular lipids due to CPT1 inhibition by excess of malonyl-CoA is often observed in IR state [38] [39] [40] . Other studies indicate, that incomplete mitochondrial FA oxidation, manifested by high content of acyl-carnitines, contributes to skeletal muscle IR [41] . In our study HFD lead to decrease in acyl-carnitine content, acyl-carnitine FSR and acyl-carnitine to LCACoA ratio. Moreover, we observed activation of ACC and accumulation of malonyl-CoA. It has to be noted that accumulation of acyl-carnitines in not universal under lipid overload in both experimental animals [42] and humans [43] , and this discrepancy could be explained by factors such as different experimental models, chow composition or species. Despite differences both mechanisms support thesis, that in IR muscle, mitochondrial FA processing is not sufficient for the high rate of cellular FA uptake, which leads to accumulation of intracellular LCACoAs and subsequently other lipids. Interestingly, improved insulin sensitivity in myriocin-treatmed animals was not associated with improved mitochondrial channeling of FA, as reflected in lower content and FSR of acyl-carnities and acyl-carnitine to LCACoA ratio. We did not observe detrimental effects of LCACoA accumulation on skeletal muscle insulin sensitivity, which points to other intramuscular lipid species as the inducers of IR.
Although strong link between the intracellular DAG accumulation and insulin resistance has been previously described in-vitro [44, 45] and in-vivo in obesity and insulin resistant states [8, 9, 46] , in a number of the studies relationship was not observed [47] . In our study increase in intramuscular DAG in HFD animals was moderate and strongly varied with acyl chain composition. Only C18:0, C18:1 and C18:2-derived molecular species displayed elevated levels, which is related to both the plasma FFA and muscle LCACoA species bioavailability. Similar DAG species composition was reported by Szendroedi et al. in obese or T2D subjects [48] . Yet the study by Selathurai et al. shows that even twofold increase in above DAG molecular species due to phosphatidylethanolamine synthesis inhibition (CTP:phosphoethanolamine cytidylyltransferase knock-out) does not affect skeletal muscle insulin sensitivity [47] . We achieved similar outcome in myriocin-treated HFD animals by re-routing LCACoA flux from de novo sphingolipids synthesis towards DAG synthesis. Nevertheless, despite significant accumulation of intramuscular LCACoA and DAG, myriocin-treated animals show improvement in insulin sensitivity and significant decrease in ceramide content. This observation strongly supports the involvement of ceramide, as opposed to DAG, in fat-induced skeletal muscle IR. In our study intramuscular ceramide accumulation in HFD animals was accompanied by IR. However, not all Cer species were equally affected. Only C18:0-Cer and C18:1-Cer species were elevated whereas C16:0-Cer remained stable. Recent studies link C16:0-Cer with hepatic insulin resistance [49, 50] whereas skeletal muscle C18-derived ceramides account for majority of Cer accumulation in HFD animals [51] , mice with uncontrolled STZ-diabetes [52] and in obese, diabetic patients [53] . Inhibition of de novo sphingolipid synthesis by myriocin also had greatest impact on C18:0-and C18:1-Cer species and was accompanied by significant improvement in both the whole-body and skeletal muscle insulin sensitivity. Despite Myr treatment SPT expression was equal in both HFD and HFD/Myr animals. Myriocin acts as suicide inhibitor of SPT by covalent modification of essential catalytic serine, thus does not affect SPT expression but completely bocks its enzymatic activity at low nanomolar concentrations [54] .
The next goal of our study was to elucidate the role of the accumulation of particular lipid species on insulin action and muscle insulin sensitivity. Previously published works demonstrated that all of the studied lipid species (LCACoA, DAG and Cer) negatively affect the insulin pathway [7, 12, [55] [56] [57] [58] . In HFD animals intramuscular lipid accumulation was visible in all above lipid classes and coincided with both local (Akt and AS160 phosphorylation) and systemic (HOMA-IR, OGTT and ITT) measures of insulin resistance. Yet significant accumulation of LCACoA and DAG in skeletal muscle of HFD/Myr animals, without adverse effects on insulin sensitivity, points at ceramide as the key lipid in induction of muscular IR. Moreover, our data indicate that IR parameters show strong correlation with muscular C18:0-Cer and C18:1-Cer content whereas relationship between DAG and IR was not visible.
Taking together, HFD leads to induction of IR manifested by increased HOMA-IR and declined response to glucose or insulin. At skeletal muscle level HFD consumption decreased both the Akt and AS160 phosphorylation (Ser473 and Thr308) as compared to control. Moreover, HFD led to increased plasma FFA concentration, and inhibited mitochondrial uptake of FA through excessive production of malonyl-CoA. In consequence, we have observed an accumulation of LCACoA, DAGs, and ceramides. Myriocin improved insulin sensitivity by enhance Akt and AS160 phosphorylation. The insulin-sensitizing effects of myriocin were accompanied by decrease in C18:0-and C18:1 ceramide. Myriocin treatment led to the improvement in insulin sensitivity through inhibition of de-novo ceramide synthesis. Although myriocin caused elevated LCACoA and DAG level, it did not affect insulin sensitivity. Our results indicate that accumulation of stearoyl and oleoyl-ceramide species plays the major role in suppressing muscle insulin action. 
